GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » Float Percentage Of Total Shares Outstanding

Sun Biomedical (ASX:SBN) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Sun Biomedical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sun Biomedical's float shares is 0.00 Mil. Sun Biomedical's total shares outstanding is 1,323.64 Mil. Sun Biomedical's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sun Biomedical's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sun Biomedical's Institutional Ownership is 0.00%.

Sun Biomedical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sun Biomedical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,323.64
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Biomedical (ASX:SBN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:RAC ASX:PIQ ASX:ALA ASX:RCE ASX:PAR ASX:AGN ASX:OCC ASX:PAA ASX:ACW ASX:LTP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
DXB:Australia
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Website
https://www.dimerix.com
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines